The contract research organisation (CRO) previously outsourced its cardiac safety studies but licensing of the software allows it to perform them in-house, according to NewCardio.
Vincent Renz, CEO of NewCardio, believes that offering this service in-house “provides a powerful competitive advantage further differentiating itself from its competitors”.
QTinno is a software suite that provides automated analysis of QT intervals and other electrocardiogram (ECG)-based cardiac safety data.